Πηγαίνετε σε ένα σημείο του ευρετηρίου:
Αποτελέσματα 1 έως 11 από 11
ΤύποςΗμερομηνίαΤίτλοςΔημιουργόςΠλήρες κείμενο
Text
2014BRAF vs RAS oncogenes: Are mutations of the same pathway equal? Differential signalling and therapeutic implicationsOikonomou E.; Koustas E.; Goulielmaki M.; Pintzas A.
Metadata only
Text
2016BRAF associated autophagy exploitation: BRAF and autophagy inhibitors synergise to efficiently overcome resistance of BRAF mutant colorectal cancer cellsGoulielmaki M.; Koustas E.; Moysidou E.; Vlassi M.; Sasazuki T.; Shirasawa S.; Zografos G.; Oikonomou E.; Pintzas A.
Metadata only
Text
2017Homeobox gene involvement in normal hematopoiesis and in the pathogenesis of childhood LeukemiasAdamaki M.; Goulielmaki M.; Christodoulou I.; Vlahopoulos S.; Zoumpourlis V.
Metadata only
Text
2017Flashback in the history of Ras researchChaldaiopoulou G.; Goulielmaki M.; Khoury N.; Zoumpourlis V.
Metadata only
Text
2017Carbon quantum dots/block copolymer ensembles for metal-ion sensing and bioimagingSkaltsas T.; Goulielmaki M.; Pintzas A.; Pispas S.; Tagmatarchis N.
Metadata only
Text
2017The dual role of mesenchymal stem cells in cancer: Putative applications for cytotherapyGoulielmaki M.; Margariti M.; Khoury N.; Georgadaki K.; Zoumpourlis V.; Christodoulou I.
Metadata only
Text
2018Mesenchymal stem cells in preclinical cancer cytotherapy: A systematic reviewChristodoulou I.; Goulielmaki M.; Devetzi M.; Panagiotidis M.; Koliakos G.; Zoumpourlis V.
Metadata only
Text
2018Genetically-modified stem cells in treatment of human diseases: Tissue kallikrein (KLK1)-based targeted therapy (Review)Devetzi M.; Goulielmaki M.; Khoury N.; Spandidos D.A.; Sotiropoulou G.; Christodoulou I.; Zoumpourlis V.
Metadata only
Text
2018Unraveling the role of autophagy in cancer: Cellular protection or cytotoxicity?Margariti M.; Goulielmaki M.; Kyriakopoulos A.; Christodoulou I.; Zoumpourlis V.
Metadata only
Text
2019Induced pluripotent stem cells: Cell therapy in regenerative medicine and modeling of human diseaseMoysidou E.; Goulielmaki M.; Christodoulou I.; Zoumpourlis V.
Metadata only
Text
2019DPS-2: A Novel Dual MEK/ERK and PI3K/AKT Pathway Inhibitor with Powerful Ex Vivo and In Vivo Anticancer PropertiesGoulielmaki M.; Assimomytis N.; Rozanc J.; Taki E.; Christodoulou I.; Alexopoulos L.G.; Zoumpourlis V.; Pintzas A.; Papahatjis D.
Metadata only